Pemigatinib Drug Interactions
Currently displaying a list of 294 drugs known to interact with pemigatinib.
- 78 major drug interactions
- 214 moderate drug interactions
- 2 minor drug interactions
Medications known to interact with pemigatinib
Note: Showing generic names only.
- abametapir topical
- adagrasib
- afatinib
- alendronate
- aliskiren
- ambrisentan
- aminoglutethimide
- amiodarone
- amlodipine
- amobarbital
- amprenavir
- apalutamide
- apixaban
- aprepitant
- armodafinil
- artesunate
- asciminib
- atazanavir
- atezolizumab
- atorvastatin
- avacopan
- avelumab
- belinostat
- belzutifan
- berotralstat
- betrixaban
- bexarotene
- bicalutamide
- boceprevir
- bosentan
- bosutinib
- brentuximab
- brigatinib
- butabarbital
- butalbital
- cabazitaxel
- calcifediol
- calcipotriene topical
- calcitriol
- calcitriol topical
- calcium glycerophosphate
- calcium phosphate, tribasic
- capivasertib
- carbamazepine
- cemiplimab
- cenobamate
- ceritinib
- chloramphenicol
- chloroquine
- cholecalciferol
- cimetidine
- ciprofloxacin
- clarithromycin
- clofazimine
- clotrimazole
- cobicistat
- cobimetinib
- colchicine
- conivaptan
- cosibelimab
- crizotinib
- cyclosporine
- dabigatran
- dabrafenib
- daclatasvir
- danazol
- daridorexant
- darolutamide
- darunavir
- dasatinib
- daunorubicin
- daunorubicin liposomal
- deferasirox
- delafloxacin
- delavirdine
- deucravacitinib
- dexamethasone
- dexlansoprazole
- digoxin
- dihydrotachysterol
- diltiazem
- docetaxel
- dostarlimab
- doxercalciferol
- doxorubicin
- dronedarone
- durvalumab
- duvelisib
- edoxaban
- efavirenz
- elafibranor
- elagolix
- eliglustat
- empagliflozin
- encorafenib
- entrectinib
- enzalutamide
- epirubicin
- erdafitinib
- ergocalciferol
- erlotinib
- erythromycin
- eslicarbazepine
- esomeprazole
- etidronate
- etoposide
- etravirine
- everolimus
- fedratinib
- felbamate
- fenfluramine
- ferric pyrophosphate
- fexinidazole
- fexofenadine
- fidaxomicin
- fluconazole
- fluvoxamine
- fosamprenavir
- fosaprepitant
- fosphenytoin
- ibandronate
- idarubicin
- idelalisib
- imatinib
- indacaterol
- indinavir
- ipilimumab
- iptacopan
- isavuconazonium
- isoniazid
- itraconazole
- ivacaftor
- ivosidenib
- ixabepilone
- lansoprazole
- lapatinib
- larotrectinib
- lazertinib
- lefamulin
- lemborexant
- lenacapavir
- lesinurad
- letermovir
- levoketoconazole
- linagliptin
- lomitapide
- lonafarnib
- lonapegsomatropin
- loperamide
- lorlatinib
- maraviroc
- maribavir
- mavacamten
- mavorixafor
- mephobarbital
- metreleptin
- mibefradil
- mifepristone
- mitapivat
- mitotane
- mitoxantrone
- mobocertinib
- modafinil
- nafcillin
- naldemedine
- naloxegol
- nefazodone
- nelfinavir
- nevirapine
- nicardipine
- nifedipine
- nilotinib
- nintedanib
- niraparib
- nirogacestat
- nivolumab
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- pamidronate
- pantoprazole
- paricalcitol
- pazopanib
- pembrolizumab
- pentobarbital
- pexidartinib
- phenobarbital
- phenylbutazone
- phenytoin
- phosphorated carbohydrate solution
- pirtobrutinib
- pitolisant
- posaconazole
- potassium phosphate
- pralsetinib
- primidone
- prucalopride
- rabeprazole
- ranolazine
- relugolix
- remdesivir
- repotrectinib
- retifanlimab
- ribociclib
- rifabutin
- rifampin
- rifapentine
- rifaximin
- rimegepant
- riociguat
- ripretinib
- risedronate
- ritlecitinib
- ritonavir
- rivaroxaban
- romidepsin
- rucaparib
- rufinamide
- saquinavir
- secobarbital
- selexipag
- selpercatinib
- silodosin
- sirolimus
- sodium glycerophosphate
- sodium phosphate
- sofosbuvir
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotorasib
- st. john's wort
- steviocalcitriol
- stiripentol
- sulfinpyrazone
- suvorexant
- suzetrigine
- talazoparib
- tazemetostat
- tecovirimat
- telaprevir
- telithromycin
- telotristat
- tenofovir alafenamide
- tenofovir disoproxil
- terfenadine
- ticagrelor
- tiludronate
- tipranavir
- tislelizumab
- tolvaptan
- topotecan
- toripalimab
- tovorafenib
- tremelimumab
- treosulfan
- trofinetide
- troglitazone
- troleandomycin
- tucatinib
- vadadustat
- vemurafenib
- venetoclax
- verapamil
- vibegron
- viloxazine
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- vonoprazan
- vorasidenib
- voriconazole
- voxelotor
Pemigatinib alcohol/food interactions
There is 1 alcohol/food interaction with pemigatinib.
Pemigatinib disease interactions
There is 1 disease interaction with pemigatinib which include:
More about pemigatinib
- pemigatinib consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Pemazyre
Pemazyre is used to treat certain types of bile duct cancer and myeloid/lymphoid neoplasms ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
Braftovi
Braftovi is a targeted cancer treatment used in combination with Mektovi, mFOLFOX6, or Erbitux, to ...
Cabometyx
Cabometyx is used to treat advanced kidney cancer, liver cancer, thyroid cancer, and pancreatic and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.